Intravenous immunoglobulin immunotherapy for coronavirus disease‐19 (COVID‐19)
Intravenous immunoglobulin immunotherapy for coronavirus disease‐19 (COVID‐19)
About this item
Full title
Author / Creator
Publisher
Australia: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Australia: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Intravenous immunoglobulin (IVIG), a pooled normal IgG from several thousand healthy donors and one of the commonly used immunotherapeutic molecules for the management of autoimmune and inflammatory diseases, has been explored for the treatment of coronavirus disease‐19 (COVID‐19). Although placebo‐controlled, double‐blind randomised clinical trial...
Alternative Titles
Full title
Intravenous immunoglobulin immunotherapy for coronavirus disease‐19 (COVID‐19)
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_9fd75b79b946404884f889a8df317c30
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9fd75b79b946404884f889a8df317c30
Other Identifiers
ISSN
2050-0068
E-ISSN
2050-0068
DOI
10.1002/cti2.1198
